NCT07579988 Ultrasound Measurement of Thyroid Volume in Term Newborns
| NCT ID | NCT07579988 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Ospedale San Raffaele |
| Condition | Thyroid Volume |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-05-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
First, to date, no data are available on the thyroid volume of full-term newborns in Italy, making it essential to conduct studies to establish reference values for normality. This allows these values to be correlated with maternal and fetal variability, providing a scientific basis for better understanding thyroid development in the first days of life. Thyroid ultrasound is useful for supplementing newborn screening for congenital hypothyroidism, helping to identify early abnormalities. Furthermore, thyroid volume is a sensitive indicator of iodine intake, essential for assessing the population's iodine nutritional status. It is equally valuable for studying and monitoring the effects of maternal and environmental factors, for which thyroid volume itself serves as a marker. Having normal values allows for a more precise comparison and contextualization of data from children with pathologies, who undergo ultrasound for pathological screening. In summary, these regulatory references improve the diagnosis, prevention, and management of neonatal thyroid dysfunction, contributing to a more informed public health.
Eligibility Criteria
Inclusion Criteria: * Healthy full term newborns (born between 37 and 42 weeks of gestation, with no antennal issue or complications at birth) * Consent obtained by parent(s) or legal guardian(s) Exclusion Criteria: * Congenital malformations * TSH abnormalities in neonatal screening * Pregnancy not carried out in Italy, due to different iodine status * Inability or unwillingness of the parent(s) or legal guardian(s) to provide informed consent or to comply with study procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07579988 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 7 Days, studying Thyroid Volume. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07579988 currently recruiting?
Yes, NCT07579988 is actively recruiting participants. Contact the research team at vigone.mariacristina@hsr.it for enrollment information.
Where is the NCT07579988 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07579988 clinical trial?
NCT07579988 is sponsored by IRCCS Ospedale San Raffaele. The trial plans to enroll 400 participants.